Skip to content
Home/Companies/Pharma/Grupo Farmaceutico Somar
Grupo Farmaceutico Somar

Grupo Farmaceutico Somar

Pharma·Mexico·Active
Entry
–
Hold
–
Status
Active

Who owns Grupo Farmaceutico Somar?

Grupo Farmaceutico Somar is a Pharma company based in Mexico, currently owned by Advent International.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Advent International
Investor
Advent International
Latin American Private Equity Fund VII · 2020 · Buyout

Key facts

HQMexico
SectorPharma
Websitewww.gruposomar.com

More from Latin American Private Equity Fund VII

Other portfolio companies in the same fund.

3i – Implant Innovations Inc.
Active
HealthcareUS
Aareon Group GmbH
Active
SaaSGermany
ABC Supply
ABC Supply
Active
ConstructionUS
AccentCare
AccentCare
Active
HealthcareUS
Addiko Bank (formerly Hypo Group Alpe Adria)
Addiko Bank (formerly Hypo Group Alpe Adria)
Active
FinancialsAustria
Aditya Birla Capital
Aditya Birla Capital
Active
FinancialsIndia

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS
Ascend Gene & Cell Therapies
Ascend Gene & Cell Therapies
Active
Cathay CapitalFrance

Questions

Who owns Grupo Farmaceutico Somar?

Grupo Farmaceutico Somar is currently owned by Advent International, through Latin American Private Equity Fund VII.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue